Impact of opioid therapy on gonadal hormones: focus on buprenorphine
Abstract
Objective The USA is in the midst of an opioid crisis. Understanding the impact of opioids and commonly used treatments for opioid dependence is essential for clinicians and researchers in order to educate and treat the nation's growing population with opioid use disorders. As a relatively new treatment for opioid dependence, buprenorphine is gaining popularity to the extent of becoming not only a preferred approach to the maintenance of opiate addiction, but also an option for chronic pain management. The purpose of this report is to review the available evidence on the endocrine effects of buprenorphine, particularly as it relates to the hypothalamic-pituitary-gonadal (HPG) axis, which is controversial and not fully defined. Method We conducted a Pubmed search (2000-2017) for human studies in the English language for articles that were available as full length regarding buprenorphine, endocrinopathy, hypogonadism, bone density, opioids. Case reports were also reviewed, although prospective studies and randomized controlled trials received more weight. Results Opioid induced hypogonadism is well established. Most studies report that buprenorphine being a partial agonist/antagonist may not be impacting the pituitary trophic hormones as much. There are reports of sexual dysfunction in subjects maintained on buprenorphine, some without hormonal correlation. Thus with the understanding that pertinent clinical studies are limited in number, varied in methodology, mostly cross sectional, predominantly in men and small number of participants, more research in this area is warranted. Conclusion Based on a comprehensive review of the available literature, we conclude that despite its increasing popularity, buprenorphine has not been adequately studied in respect to its long-term effects on the hypothalamic-pituitary-adrenal (HPA) axis. There is a great need for longitudinal systematic trials to define the potential buprenorphine-induced endocrine consequences.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Buprenorphine, a partial opioid receptor agonist, is associated with milder effects on the hypothalamic-pituitary-gonadal system.
“Buprenorphine, a partial opioid receptor agonist, is associated with milder effects on the hypothalamic-pituitary-gonadal system (91,92).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [92]
Cites
Hypogonadism in men consuming sustained-action oral opioids
Daniell, H. W. (2002) · The Journal of Pain · doi:10.1054/jpai.2002.126790 · Cited by 401 · see citing works
Daniell, H. W. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.08.005 · Cited by 263 · cited 3× · see citing works
“The effects of long-term opioids including methadone on gonadal hormones are unanimously accepted [10], [11] in both sexes.”
BackgroundColuzzi, F., Mattia, C., Raffa, R. R., & Pergolizzi, J. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s79409 · Cited by 77 · see citing works
Impaired circadian rhythmicity of β-lipotrophin, β-endorphin and ACTH in heroin addicts
Facchinetti, F., Grasso, A., Petraglia, F., Parrini, D., Volpe, A., & Genazzani, A. R. (1984) · Acta Endocrinologica · doi:10.1530/acta.0.1050149 · Cited by 61 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Opioid-induced endocrinopathies
Fountas, A., Van Uum, S., & Karavitaki, N. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30254-2 · Cited by 77 · see citing works
The effect of opiates on bone formation and bone healing
Coluzzi, F., Scerpa, M. S., & Centanni, M. (2020) · Current Osteoporosis Reports · doi:10.1007/s11914-020-00585-4 · Cited by 55 · see citing works
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14 · see citing works
Zelfand, E. (2020) · Integrative Medicine · Cited by 8 · see citing works
- Authors
- Varma, A., Sapra, M., & Iranmanesh, A.
- Affiliations
- Veterans Health Administration (US)
- Corresponding author
- Varma, Anjali
- ORCID
- Iranmanesh, Ali
- Venue
- Hormone Molecular Biology and Clinical Investigation
- Publisher
- Walter de Gruyter GmbH
- Published
- 2018-02-17
- Volume
- 36
- Issue
- 2
- ISSN
- 1868-1883 (ISSN-L)
- 1868-1891
- OpenAlex
- W2790656516
- Cited by
- 15
- References
- 4
- Citations by year
- 2026: 1 · 2024: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 5
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Hormone Molecular Biology and Clinical Investigation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- buprenorphine, opioid use disorder, opioid dependence treatment, hypothalamic-pituitary-gonadal axis, hypogonadism, gonadal hormones, sexual dysfunction, bone mineral density, opioid epidemic, chronic pain management
- MeSH terms
- Animals, Buprenorphine, Gonads, Humans, Hypothalamo-Hypophyseal System, Narcotic Antagonists, Pituitary-Adrenal System, Gonadal Hormones, Opiate Substitution Treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review